ISRCTN72821613进行中（未招募）4 期
The effect of a two-dose compared to a three-dose schedule of pneumococcal conjugate vaccine on pneumococcal acquisition, immunogenicity, and co-administration of pneumococcal conjugate and yellow fever vaccines
ondon School of Hygiene & Tropical Medicine0 个研究点目标入组 827 人开始时间: 2019年11月28日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 827
研究概览
简要总结
2022 Protocol article in https://doi.org/10.1186/s13063-021-05949-4 (added 24/05/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Resident in the study area (PVS-AcqImm trial)
- •2. Age 0-6 weeks
- •3. Intention to reside in cluster until 18 months of age
排除标准
- •1. Intent to move out of the study area before 18 months of age
- •2. Age greater than 6 weeks
- •3. Prematurity <34 weeks gestation
- •4. Birth weight <2.0kg or weight <2.5 kg
- •5. History of invasive bacterial infection or measles
- •6. Receiving long-term antibiotic therapy, defined as greater than 4 weeks
- •7. HIV infection in the infant or mother
- •8. Chronic debilitating illness
- •9. Immunosuppressive therapy or immunodeficiency disorder
- •10. Contraindication to PCV13 – severe hypersensitivity to a previous dose of PCV13
- •11. Contraindication to YF vaccine
研究者
相似试验
招募中
4 期
Pneumococcal Vaccine Schedules Acquisition-ImmunogenicityPACTR202105670402672ondon School of Hygiene and Tropical Medicine784
招募中
4 期
Comparative Effectiveness of Two Doses Versus Three Doses of Hepatitis A Vaccine in Kidney transplant recipients in Chulalongkorn hospitalPrevalence of hepatitis AHepatitis A vaccineThree doses of hepatitis A vaccineKidney transplant recipientsHepatitis AAllergyTCTR20180325001Faculty of Medicine Chulalongkorn university400
已完成
4 期
Immunogenicity of Rabies Vaccine for Pre Exposure ProphylaxisRabiesNCT02374814State University of New York - Upstate Medical University60
已完成
3 期
A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult ParticipantsEbolaNCT04228783Janssen Vaccines & Prevention B.V.974
终止
2 期
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular DegenerationAge-Related MaculopathyNCT01577381Pfizer10